1,3-dihydroxy-2-hydroxymethyl-9,10-anthraquinone,
lucidin,
Lucidin,
478-08-0,
Henine,
Lucidin (quinone),
1,3-Dihydroxy-2-(hydroxymethyl)anthraquinone,
CCRIS 1642,
1,3-dihydroxy-2-(hydroxymethyl)anthracene-9,10-dione,
UNII-60Q5564O9D,
HSDB 7146,
NSC 30546,
BRN 1888954,
1,3-Dihydroxy-2-hydroxymethylanthraquinoline,
Anthraquinone, 1,3-dihydroxy-2-(hydroxymethyl)-,
60Q5564O9D,
ANTHRAQUINONE, 1,3-DIHYDROXY-2-HYDROXYMETHYL-,
1,3-dihydroxy-2-(hydroxymethyl)-9,10-anthraquinone,
AC1L1UMN,
AC1Q6JWW,
Lucidin (NSC 30546),
4-08-00-03576 (Beilstein Handbook Reference),
SCHEMBL705681,
CHEBI:6554,
CTK4J0338,
DTXSID10197278,
NSC30546,
ZINC4098684,
3789AH,
FD5009,
MFCD01664482,
NSC-30546,
AKOS027328039,
CS-1555,
QC-5142,
9, 1,3-dihydroxy-2-(hydroxymethyl)-,
HY-15733,
LS-20675,
SC-94284,
WLN: L C666 BV IVJ DQ E1Q FQ,
AB0087815,
FT-0744982,
Anthraquinone,3-dihydroxy-2-(hydroxymethyl)-,
C10369,
9,10-Anthracenedione,1,3-dihydroxy-2-(hydroxymethyl)-,
9,10-Anthracenedione, 1,3-dihydroxy-2-(hydroxymethyl)-,
9,10-Anthracenedione, 1,3-dihydroxy-2-(hydroxymethyl)- (9CI),
KST-1B4589,
C15H10O5,
CID10163,
AR-1B6931,
ACN-056731,
C15-H10-O5,
A3562,
A15146,
5061-27-8,